Distribution of immunoreactive glutamine synthetase in the adult human and mouse brain. Qualitative and quantitative observations with special emphasis on extra-astroglial protein localization

Journal of Chemical Neuroanatomy

Volumn 61, Issue , 2014, Pages 33-50

  Bernstein, Hans Gert ^a   Bannier, Jana ^a   Meyer Lotz, Gabriela ^a   Steiner, Johann ^a   Keilhoff, Gerburg ^a   Dobrowolny, Henrik ^a   Walter, Martin ^a,b   Bogerts, Bernhard ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b LEIBNIZ INSTITUTE FOR NEUROBIOLOGY   (Germany)

Author keywords

Astrocytes; Cell culture; Glutamine synthetase immunohistochemistry; Mouse brain; Neurons; Oligodendrocytes; Post mortem human brain

Indexed keywords

GLUTAMATE AMMONIA LIGASE; NEURONAL NITRIC OXIDE SYNTHASE; PARVALBUMIN;

ADULT; ANIMAL CELL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; ASTROCYTE; AUTOPSY; BRAIN CELL CULTURE; BRAIN NERVE CELL; BRAIN SLICE; CELL SUBPOPULATION; CONTROLLED STUDY; ENZYME LOCALIZATION; EPENDYMA CELL; FEMALE; GRAY MATTER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; MICROGLIA; MOUSE; NITRERGIC NERVE; NONHUMAN; OLIGODENDROGLIA; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; WHITE MATTER; ANIMAL; BIOSYNTHESIS; BRAIN; C57BL MOUSE; CADAVER; ENZYMOLOGY; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; MIDDLE AGED; NERVE CELL; ANTERIOR CINGULATE; BRAIN CORTEX; BRAIN STEM; BRAIN TISSUE; CEREBELLUM; CHOROID PLEXUS; CLAUSTRUM; DORSOLATERAL PREFRONTAL CORTEX; EPITHALAMUS; GENICULATE BODY; GLOBUS PALLIDUS; HABENULA; HIPPOCAMPUS; HYPOTHALAMUS; IMMUNOLOCALIZATION; INSULA; MESENCEPHALON; NUCLEUS ACCUMBENS; POSTERIOR CINGULATE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PUTAMEN; SEPTUM PELLUCIDUM; SUBFORNICAL ORGAN; THALAMUS; THALAMUS NUCLEUS;

ANIMALS; ASTROCYTES; BRAIN; CADAVER; FEMALE; GLUTAMATE-AMMONIA LIGASE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MIDDLE AGED; NEURONS; OLIGODENDROGLIA;

EID: 84916222733     PISSN: 08910618     EISSN: 18736300     Source Type: Journal    
DOI: 10.1016/j.jchemneu.2014.07.003     Document Type: Article

References (66)

1. Akbarian S., Vinuela A., Kim J.J., Potkin S.G., Bunney W.E., Jones E.G. Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development. Arch. Gen. Psychiatry 1993, 150:178-187.
2. Albrecht J., Sidoryk-Wegrzynowicz M., Zielinska M., Aschner M. Roles of glutamine in neurotransmission. Neuron Glia Biol. 2010, 6:263-276.
3. Alm P., Skagerberg G., Nylen A., Larsson B., Andersson K.E. Nitric oxide synthase and vasopressin in rat circumventricular organs. An immunohistochemical study. Exp. Brain Res. 1997, 117:59-66.
4. Anlauf E., Derouiche A. Glutamine synthetase as an astrocytic marker: its cell type and vesicle localization. Front. Endocrinol. 2013, 4:144.
5. Baas D., Fressinaud C., Vitkovic L., Sarlieve L.L. Glutamine synthetase expression and activity are regulated by 3,5,3'-triodo-l-thyronine and hydrocortisone in rat oligodendrocyte cultures. Int. J. Dev. Neurosci. 1998, 16:333-340.
6. Baumann N., Pham-Dinh D. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol. Rev. 2001, 81:871-927.
7. Bernstein H.-G., Keilhoff G., Seidel B., Stanarius A., Huang P.L., Fishman M.C., Reiser M., Bogerts B., Wolf G. Expression of hypothalamic peptides in mice lacking neuronal nitric oxide synthase: reduced beta-END immunoreactivity in the arcuate nucleus. Neuroendocrinology 1998, 68:403-411.
8. Bernstein H.-G., Stanarius A., Baumann B., Henning H., Krell D., Danos P., Falkai P., Bogerts B. Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics. Neuroscience 1998, 83:867-875.
9. Bernstein H.G., Krell D., Braunewell K.H., Baumann B., Gundelfinger E.D., Diekmann S., Danos P., Bogerts B. Increased number of nitric oxide synthase immunoreactive Purkinje cells and dentate nucleus neurons in schizophrenia. J. Neurocytol. 2001, 30:661-670.
10. Bernstein H.-G., Brisch R., Ogonlade V., Heinemann A., Baumann B., Arendt T., Dobrowolny H., Bogerts B., Lüth H.J. Detection of nitric oxide synthase (NOS) immunoreactive neurons in the human septal area: a matter of method?. J. Chem. Neuroanat. 2004, 27:247-250.
11. Bernstein H.-G., Heinemann A., Krell D., Dobrowolny H., Bielau H., Keilhoff G., Bogerts B. Hypothalamic nitric oxide synthase in affective disorder: focus on the suprachiasmatic nucleus. Cell. Mol. Biol. (Noisy-le-grand) 2005, 51:279-284.
12. Bernstein H.-G., Stich C., Jäger K., Dobrowolny H., Wick M., Steiner J., Veh R., Bogerts B., Laube G. Agmatinase, an inactivator of the putative endogenous antidepressant agmatine, is strongly upregulated in hippocampal interneurons of subjects with mood disorders. Neuropharmacology 2012, 62:237-246.
13. Bernstein H.-G., Tausch A., Wagner R., Steiner J., Seeleke P., Walter M., Dobrowolny H., Bogerts B. Disruption of glutamate-glutamine-GABA cycle significantly impacts on suicidal behaviour: survey of the literature and own findings on glutamine synthetase. CNS Neurol. Disord. Drug Targets 2013, 12:900-913.
14. Bernstein H.-G., Trübner K., Krebs P., Dobrowolny H., Bielau H., Steiner J., Bogerts B. Increased densities of nitric oxide synthase expressing neurons in the temporal cortex and the hypothalamic paraventricular nucleus of polytoxicomanic heroin overdose victims: possible implications for heroin neurotoxicity. Acta Histochem. 2014, 116:182-190.
15. Bickford M.E., Ramcharan E., Godwin D.W., Erişir A., Gnadt J., Sherman S.M. Neurotransmitters contained in the subcortical extraretinal inputs to the monkey lateral geniculate nucleus. J. Comp. Neurol. 2000, 424:701-717.
16. Bielau H., Brisch R., Bernard-Mittelstaedt J., Dobrowolny H., Gos T., Baumann B., Mawrin C., Bernstein H.-G., Bogerts B., Steiner J. Immunohistochemical evidence for impaired nitric oxide signaling of the locus coeruleus in bipolar disorder. Brain Res. 2012, 1459:91-99.
17. Brusilow S.W., Koehler R.C., Traystman R.J., Cooper A.J. Astrocyte glutamine synthetase: importance in hyperammonemic syndromes and potential target for therapy. Neurotherapeutics 2010, 7:452-470.
18. Burbaeva G.Sh., Boksha I.S., Turishcheva M.S., Vorobyeva E.A., Savushkina O.K., Tereshkina E.B. Glutamine synthetase and glutamate dehydrogenase in the prefrontal cortex of patients with schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2003, 27:675-680.
19. Burbaeva G.Sh., Boksha I.S., Tereshkina E.B., Savushkina O.K., Turishcheva M.S., Starodubtseva L.I., Brusov O.S., Morozova M.A. Effect of olanzapine treatment on platelet glutamine synthetase-like protein and glutamate dehydrogenase immunoreactivity in schizophrenia. World J. Biol. Psychiatry 2006, 7:75-81.
20. Cammer W. Glutamine synthetase in the central nervous system is not confined to astrocytes. J. Neuroimmunol. 1990, 26:173-178.
21. Carter C.J. Loss of glutamine synthetase activity in the brain in Huntington's disease. Lancet 1981, 1(8223):782-783.
22. Caviness V.S. Architectonic map of neocortex of the normal mouse. J. Comp. Neurol. 1975, 164:247-263.
23. Chandley M.J., Szebeni K., Szebeni A., Crwaford J., Stockmeyer C.A., Turecki G., Miguel-Hidalgo J.J., Ordway G.A. Gene expression deficits in pontine locus coeruleus astrocytes in men with major depressive disorder. J. Psychiatry Neurosci. 2013, 38:276-284.
24. Connor C.M., Crwaford B.C., Akbarian S. White matter neuron alterations in schizophrenia and related disorders. Int. J. Dev. Neurosci. 2011, 9:325-334.
25. Dadsetan S., Kukolj E., Bak L.K., Sørensen M., Ott P., Vilstrup H., Schouboe A., Keiding S., Waagepetersen H.S. Brain alanine formation as an ammonia-scavenging pathway during hyperammonemia: effects of glutamine synthetase inhibition in rats and astrocyte-neuron co-cultures. J. Cereb. Blood Flow Metab. 2013, 33:1235-1241.
26. D'Amelio F., Eng L.F., Gibbs M.A. Glutamine synthetase immunoreactivity is present in oligodendroglia of various regions of the central nervous system. Glia 1990, 3:335-341.
27. Edelstein L., Hinova-Palova D., Denaro F.J., Landzhov B., Malinova L., Minkov M., Paloff A., Ovtscharoff W. Neuronal nitric oxide synthase immunoreactivity in the human claustrum: light and electron microscopic investigation. FN Neuroscience Meeting New Orleans 2012, abstr. 895.20.
28. Egberongbe Y.I., Gentleman S.M., Falkai P., Bogerts B., Polak J.M., Roberts G.W. The distribution of nitric oxide synthase immunoreactivity in the human brain. Neuroscience 1994, 59:561-578.
29. Eve D.J., Nisbet A.P., Kingsbury A.E., Hewson E.L., Daniel S.E., Lees A.J., Marsden C.D., Foster O.J. Basal ganglia neuronal nitric oxide synthase mRNA expression in Parkinson's disease. Brain Res. Mol. Brain Res. 1998, 63:62-71.
30. Fernandes S.P., Dringen R., Lawen A., Robinson S.R. Neurones express glutamine synthetase when deprived of glutamine or interaction with astrocytes. J. Neurochem. 2010, 114:1527-1536.
31. Fressinaud C., Weinrauder H., Delaunoy J.P., Tholey G., Labourdette G., Sarliève L.L. Glutamine synthetase expression in rat oligodendrocytes in culture: regulation by hormones and growth factors. J. Cell Physiol. 1991, 149:459-468.
32. Gao S.F., Qi X.R., Zhao J., Balesar R., Bao A.M., Swaab D.F. Decreased NOS1 expression in the anterior cingulate cortex in depression. Cereb. Cortex. 2013, 23:2956-2964.
33. Garbossa D., Fontanella M., Tomasi S., Ducati A., Vercelli A. Differential distribution of NADPH-diaphorase histochemistry in human cerebral cortex. Brain Res. 2005, 1034:1-10.
34. Gerlach M., Blum-Degen D., Ransmayr G., Leblhuber F., Pedersen V., Riederer P. Expression, but not activity, of neuronal nitric oxide synthase is regionally increased in the alcoholic brain. Alcohol Alcohol. 2001, 65-69.
35. Gödecke A., Decking U.K., Ding Z., Hirchenhain J., Bidmon H.J., Gödecke S., Schrader J. Coronary hemodynamics in endothelial NO synthase knockout mice. Circ. Res. 1998, 82:186-194.
36. Goursaudm S., Kozlova E.N., Maloteux J.M., Hermans E. Cultured astrocytes derived from corpus callosum or cortical grey matter show distinct glutamate handling properties. J. Neurochem. 2009, 108:1442-1452.
37. Graff M.N., baas D., Puymirat J., Salieve L.L., Delaunoy J.P. The alpha and beta thyroid receptors are expressed by cultured ependymal cells. Correlation with the effect of l-3,5,3'-triiodothyronine on glutamine synthetase mRNAs. Neurosci. Lett. 1993, 150:174-178.
38. Holten A.T., Gundersen V. Glutamine as a precursor for transmitter glutamate, aspartate and GABA in the cerebellum: a role for phosphate-activated glutaminase. J. Neurochem. 2008, 104:1032-1042.
39. Hu Z., Rudd J.A., Fang M. Development of the human corpus striatum and the presence of nNOS and 5-HT2A receptors. Anat. Rec. 2012, 295:127-131.
40. Huang P.-L., Dawson T.M., Bredt D.S., Snyder S.H., Fishman M.C. Targeted disruption of the neuronal nitric oxide synthase gene. Cell 1993, 75:1273-1286.
41. Hunot S., Boissière F., Faucheux B., Brugg B., Mouatt-Prigent B., Agid Y., Hirsch E.C. Nitric oxide synthase and neuronal vulnerability in Parkinson's disease. Neuroscience 1996, 72:355-363.
42. Johannes S., Reif A., Senitz D., Riederer P., Lauer M. NADPH-diaphorase staining reveals new types of interneurons in human putamen. Brain Res. 2003, 980:92-99.
43. Karson C.N., Griffin W.S., Mrak R.E., Husain M., Dawson T.M., Snyder S.H., Moore N.C., Sturner W.Q. Nitric oxide synthase (NOS) in schizophrenia: increases in cerebellar vermis. Mol. Chem. Neuropathol. 1996, 27:275-284.
44. Keilhoff G., Becker A., Grecksch G., Wolf G., Bernstein H.-G. Repeated application of ketamine to rats induces changes in the hippocampal expression of parvalbumin, neuronal nitric oxide synthase and cFOS similar to those found in human schizophrenia. Neuroscience 2004, 126:591-598.
45. Kosenko E., Llansola M., Montoliu C., Monfort P., Rodrigo R., Hernandez-Viadel M., Erceg S., Sánchez-Perez A.M., Felipo V. Glutamine synthetase activity and glutamine content in brain: modulation by NMDA receptors and nitric oxide. Neurochem. Int. 2003, 43:493-499.
46. Liu C., Wu W., Zhang B., Xiang J., Zou J. Temporospatial expression and cellular localization of glutamine synthetase following traumatic spinal cord injury in adult rats. Mol. Med. Rep. 2013, 7:1431-1436.
47. Lüth H.J., Münch G., Arendt T. Aberrant expression of NOS isoforms in Alzheimer's disease is structurally related to nitrotyrosine formation. Brain Res. 2002, 953:135-143.
48. Mai J.K., Paxinos G., Voss T. Atlas of the Human Brain 2007, Academic Press, New York.
49. Martins A.R., Zanella C.A., Zucchi F.C., Dombroski T.C., Costa E.T., Guethe L.M., Oliveira A.O., Donatti A.L., Neder L., Chimelli L., De Nucci G., Lee-Ho P., Murad F. Immunolocalization of nitric oxide synthase isoforms in human archival and rat tissues, and cultured cells. J. Neurosci. Methods 2011, 198:16-22.
50. Miguel-Hidalgo J.J., Waltzer R., Whittom A.A., Austin M.C., Rajkowska G., Stockmeier C.A. Glial and glutamatergic markers in depression, alcoholism, and their comorbidity. J. Affect. Disord. 2010, 127:230-240.
51. Miyake T., Kitamura T. Glutamine synthetase immunoreactivity in two types of mouse brain glial cells. Brain Res. 1992, 586:53-60.
52. Nisbet A.P., Foster O.J., Kingsbury A., Lees A.J., Marsden C.D. Nitric oxide synthase mRNA expression in human subthalamic nucleus, striatum and globus pallidus: implications for basal ganglia function. Brain Res. Mol. Brain Res. 1994, 22:329-332.
53. Olabarria M., Noristani H.N., Verkhratsky A., J.J.Rodríguez J.J. Age-dependent decrease in glutamine synthetase expression in the hippocampal astroglia of the triple transgenic Alzheimer's disease mouse model: mechanism for deficient glutamatergic transmission?. Mol. Neurodegener. 2011, 6:55.
54. Oliveira R.M., Guimarães F.S., Deakin J.F. Expression of neuronal nitric oxide synthase in the hippocampal formation in affective disorders. Braz. J. Med. Biol. Res. 2008, 41:333-341.
55. Pilkington G.J., Lantos P.L. The role of glutamine synthetase in the diagnosis of cerebral tumours. Neuropathol. Appl. Neurobiol. 1982, 8:227-236.
56. Reisin H.D., Colombo J.A. Considerations on the astroglial architecture and the columnar organization of the cerebral cortex. Cell. Mol. Neurobiol. 2002, 22:633-644.
57. Robinson S.R. Neuronal expression of glutamine synthetase in Alzheimer's disease indicates a profound impairment of metabolic interactions with astrocytes. Neurochem. Int. 2000, 36:471-482.
58. Robinson S.R. Changes in the cellular distribution of glutamine synthetase in Alzheimer's disease. J. Neurosci. Res. 2001, 66:972-980.
59. Rodrigo J., Riveros-Moreno V., Bentura M.L., Uttenthal L.O., Higgs E.A., Fernandez A.P., Polak J.M., Moncada S., Martínez-Murillo R. Subcellular localization of nitric oxide synthase in the cerebral ventricular system, subfornical organ, area postrema, and blood vessels of the rat brain. J. Comp. Neurol. 1997, 378:522-534.
60. Rodrigo R., Felipo V. Control of brain glutamine synthesis by NMDA receptors. Front. Biosci. 2007, 12:883-890.
61. Smalla K.H., Mikhaylova M., Sahin J., Bernstein H.G., Bogerts B., Schmitt A., van der Schors R., Smit A.B., Li K.W., Gundelfinger E.D., Kreutz M.R. A comparison of the synaptic proteome in human chronic schizophrenia and rat psychosis suggest that prohibitin is involved in the synaptic pathology of schizophrenia. Mol. Psychiatry 2008, 13:878-896.
62. Sosunov A.A., Wu X., Tsankova N.M., Guilfoyle E., MsCann G.M., Goldman J.E. Phenotypic heterogeneity and plasticity of isocortical and hippocampal astrocytes in the human brain. J. Neurosci. 2014, 34:2285-2298.
63. Suchet S., Nielsen J.A., Lovac G., Domowicz M.S., de Velasco J.M., Maric D., Hudson L.D. The genetic signature of perineuronal oligodendrocytes reveals their unique phenotype. Eur. J. Neurosci. 2011, 34:1906-1922.
64. Takasaki C., Yamasaki M., Uchigashima M., Konno K., Yanagawa Y., Watanabe M. Cytochemical and cytological properties of perineuronal oligodendrocytes in the mouse cortex. Eur. J. Neurosci. 2010, 32:1326-1336.
65. Tansey F.A., Farooq M., Cammer W. Glutamine synthetase in oligodendrocytes and astrocytes: new biochemical and immunocytochemical evidence. J. Neurochem. 2009, 108:1442-1452.
66. Zhuang Z., Qi M., Li J., Okamoto H., Xu D.S., Iyer R.R., Lu J., Yang C., Vortmeyer A., Lonser R.R. Proteomic identification of glutamine synthetase as a differential marker for oligodendrogliomas and astrocytomas. J. Neurosurg. 2011, 115:789-795.